Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophenol vs dexmedetomidine with remifentanil for fiberoptic bronchoscopy sedation
ChiCTR2200062763Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Aug 2022
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ciprofol in None (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Success rate of operation completion. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2200062763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062763.